I'rom Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares I'rom Group Co Ltd with three other
pharmaceutical manufacturers in Asia:
Mangalam Drugs & Organics Limited
sales of 3.03 billion Indian Rupees [US$46.25 million]
Astec LifeSciences Limited
(2.99 billion Indian Rupees [US$45.61 million]
DHP Korea Co Ltd
based in South Korea
(49.81 billion Korean Won [US$46.52 million]
During the year ended March of 2017, sales at
I'rom Group Co Ltd were ¥4.89 billion (US$45.67 million).
increase of 18.9%
versus 2016, when the company's sales were ¥4.11 billion.
Sales of Smo Business saw an increase
21.3% in 2017, from
¥2.98 billion to ¥3.61 billion.
Not all segments of I'rom Group Co Ltd experienced an increase in sales in 2017:
sales of Other Businesses fell 46.2% to ¥14.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).